✨ Financial and Regulatory Notices
15 OCTOBER THE NEW ZEALAND GAZETTE 4731
RESERVE BANK OF NEW ZEALAND
STATEMENT OF ASSETS AND LIABILITIES OF THE RESERVE BANK OF NEW ZEALAND AS AT THE CLOSE OF BUSINESS ON WEDNESDAY 23 SEPTEMBER 1987
Liabilities Assets
$(000) $(000)
Overseas liabilities— Overseas assets—
Denominated in overseas currencies— Denominated in overseas currencies—
(a) Short term 3,169,314 (a) Short term 3,787,812
(b) Long term 280,382 (b) Long term 11,961
Denominated in New Zealand currency— (c) Holdings of I.M.F. special drawing
(a) Short term 50,321 rights 6,181
(b) Long term - Denominated in New Zealand currency—
3,500,017 (a) Short term 2,443
Allocation of special drawing rights by I.M.F. (b) Long term 699
282,700 3,809,096
Deposits—
(a) State:
Public account - Advances and discounts—
Other 113,706 (a) State:
(b) Marketing organisations 209 Public account 162,459
(c) Stabilisation accounts 83,428 Other 121,453
(d) Trading banks 32,375 (b) Marketing organisations 659
(e) Other 15,111 (c) Stabilisation accounts -
244,829 (d) Trading banks:
Notes in circulation 938,131 Compensatory deposits -
Other liabilities 124,851 Other 2,101
Reserves— (e) Other 148
(a) General reserve 187,616 286,820
(b) Other reserves 91,956 Term Loans—
(c) Profit and loss appropriation account Marketing organisations 50,000
279,572 Investments in New Zealand—
$5,370,100 (a) New Zealand Government
securities 1,086,032
(b) Other 6,875
Other assets 1,092,907
131,277
$5,370,100
G. K. FROGGATT, Chief Manager, Corporate Services.
Consent to the Distribution of a New Medicine
PURSUANT to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
SCHEDULE
Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Hepatitis B Surface antigen Injection Merck Sharp & Dohme, USA HB VAX II
isolated from yeast cells and
modified by recombinant
DNA methods, 10 mcg in
1 ml and 5 mcg in 0.5 ml.
Dated this 6th day of October 1987.
DAVID CAYGILL, Minister of Health.
Notice by Commerce Commission of Clearances of Merger and Takeover Proposals
NOTICE is hereby given that the Commerce Commission has given clearance to the following merger and takeover proposals in terms of 66 (3) (a) of the Commerce Act 1986.
Person by or on behalf of whom notice was given in terms of section 66 (1) of the Commerce Act 1986
Richmond Ltd. Proposal: Richmond Ltd. may acquire all the assets and business carried on by The Hawkes Bay Farmers Meat Company Ltd. at Takapau
New Zealand Equities Ltd. Proposal: New Zealand Equities Ltd. may acquire up to 100 percent of the issued share capital in Zino Securities Ltd.
Date of Clearance Commission Reference
30 September 1987 AUT/MT-R23/1
30 September 1987 AUT/MT-N3/4
Dated at Wellington this 6th day of October 1987.
D. T. WOGAN, for Commerce Commission.
20
3
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1987, No 178
NZLII —
NZ Gazette 1987, No 178
✨ LLM interpretation of page content
💰 Reserve Bank of New Zealand Statement of Assets and Liabilities
💰 Finance & Revenue23 September 1987
Assets, Liabilities, Financial Statement, Reserve Bank
- G. K. Froggatt, Chief Manager, Corporate Services
🏥 Consent to Distribution of New Medicine
🏥 Health & Social Welfare6 October 1987
Medicine, Hepatitis B Vaccine, Distribution Consent
- David Caygill, Minister of Health
🏭 Commerce Commission Clearances of Merger and Takeover Proposals
🏭 Trade, Customs & Industry6 October 1987
Merger, Takeover, Clearance, Commerce Commission
- D. T. Wogan, for Commerce Commission